Pyrotinib Maleate Tablets are available for purchase at local hospitals, chain or independent pharmacies, as well as online pharmacies with official qualifications. These are all legitimate pharmaceutical sales channels in compliance with relevant national regulations, ensuring the quality of the drugs sold. However, this drug is a prescription medication. Patients should remember to carry a valid doctor's prescription when purchasing it. Some online pharmacies have onboard licensed online physicians who can also issue prescriptions for purchase upon assessment.
Pyrotinib Maleate Tablets are indicated for the treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive recurrent or metastatic breast cancer who have not previously received trastuzumab or have undergone prior trastuzumab therapy.
Patients should be aware of the following contraindications and precautions:
I. Contraindicated Populations
Patients hypersensitive to pyrotinib or any component of this product are prohibited from taking it.
The safety and efficacy of this product in pregnant women have not been clearly established; therefore, pregnant women should use this product with extreme caution.
It remains unknown whether this product is excreted in human milk. Given that many drugs are secreted in breast milk, lactating women are advised to discontinue breastfeeding during the course of treatment to avoid potential adverse effects on infants.
II. Contraindicated Practices
Do not store this product within the reach of children to prevent accidental ingestion.
This product may interact with other medications. Patients must not take other drugs without the guidance of a healthcare provider to avoid the risk of adverse drug interactions.
